XLRN

Acceleron Pharma
XLRN

Delisted

XLRN was delisted on the 19th of November, 2021.

172 hedge funds and large institutions have $1.9B invested in Acceleron Pharma in 2019 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 58 increasing their positions, 62 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more funds holding in top 10

Funds holding in top 10:

less capital invested

Capital invested by funds: $ → $

6% less repeat investments, than reductions

Existing positions increased: 58 | Existing positions reduced: 62

33% less call options, than puts

Call options by funds: $5.12M | Put options by funds: $7.66M

Holders
172
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.12M
Puts
$7.66M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$235M
2
$204M
3
$165M
4
$135M
5
$94.8M
6
$59.4M
7
$59.3M
8
$57.5M
9
$56.2M
10
$53.2M
11
$51.6M
12
$48.9M
13
$41.4M
14
$37.3M
15
$36.3M
16
$31M
17
$29.6M
18
$29.1M
19
$26M
20
$24.3M
21
$22.1M
22
$21.8M
23
$21.2M
24
$16.1M
25
$15.7M